| __timestamp | BeiGene, Ltd. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21862000 | 31354781 |
| Thursday, January 1, 2015 | 58250000000 | 43445817 |
| Friday, January 1, 2016 | 98033000 | 66489820 |
| Sunday, January 1, 2017 | 269018000 | 96886134 |
| Monday, January 1, 2018 | 679005000 | 153793000 |
| Tuesday, January 1, 2019 | 927338000 | 148369000 |
| Wednesday, January 1, 2020 | 1294877000 | 151934000 |
| Friday, January 1, 2021 | 1459239000 | 198532000 |
| Saturday, January 1, 2022 | 1640508000 | 112128000 |
| Sunday, January 1, 2023 | 1778594000 | 76192000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. BeiGene, Ltd. and TG Therapeutics, Inc. are two prominent players in this field, each with a distinct approach to R&D investment. Over the past decade, BeiGene has consistently outpaced TG Therapeutics in R&D spending, with a staggering 2,000% increase from 2014 to 2023. In contrast, TG Therapeutics has maintained a more modest growth, with R&D expenses peaking in 2021. This disparity highlights BeiGene's aggressive strategy to lead in innovation, while TG Therapeutics adopts a more conservative approach. As the biotech industry continues to evolve, these spending patterns may influence their future market positions and breakthroughs.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and BeiGene, Ltd.
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
R&D Spending Showdown: BeiGene, Ltd. vs MorphoSys AG
R&D Insights: How BeiGene, Ltd. and MannKind Corporation Allocate Funds
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
TG Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Comparing Innovation Spending: TG Therapeutics, Inc. and Novavax, Inc.